Cargando…
Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
Symptomatic intracranial hemorrhage (sICH) is a known complication following administration of intravenous tissue plasminogen activator (IV tPA) for acute ischemic stroke. sICH results in high rates of death or long-term disability. Our ability to predict its occurrence is important in clinical deci...
Autores principales: | Marsh, Elisabeth B., Gottesman, Rebecca F., Hillis, Argye E., Urrutia, Victor C., Llinas, Rafael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442012/ https://www.ncbi.nlm.nih.gov/pubmed/24145699 http://dx.doi.org/10.1097/MD.0000000000000006 |
Ejemplares similares
-
Causes, Predictors, and Timing of Early Neurological Deterioration and Symptomatic Intracranial Hemorrhage After Administration of IV tPA
por: Shah, Kavit, et al.
Publicado: (2021) -
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
por: Foerch, Christian, et al.
Publicado: (2013) -
Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA - Does One Size Fit All?
por: Faigle, Roland, et al.
Publicado: (2015) -
Impacts of tissue-type plasminogen activator (tPA) on neuronal survival
por: Chevilley, Arnaud, et al.
Publicado: (2015) -
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)